Back to search

National and Kapodistrian University of Athens

Επιδημιολογική μελέτη και διερεύνηση πλασμιδιακών AmpC β-λακταμασών και καρβαπενεμασών στα εντεροβακτηριοειδή στην ελληνική επικράτεια

Abstract

dc:description

The present study has been focused on two main objectives on the one hand the detection andcharacterization of plasmid-mediated AmpC β-lactamases in Enterobacteriaceae, along withan evaluation of the effectiveness of various inhibitors in their detection and an assessment ofa modified CLSI-ESBL test and on the other hand the investigation of novel carbapenemasegenes which have recently been introduced to the Greek region.A total of 105 Enterobacteriaceae isolates (K.pneumoniae, E.coli, K.oxytoca, P.mirabilis)collected over a 9 year period from 2004 to 2012, exhibiting reduced susceptibility orresistance either to cefoxitin (FOX) and/or cefotetan (CTT) along with reduced susceptibility or resistance to at least one extended spectrum cephalosporin were further investigated for thepresence of plasmid AmpC β-lactamases. Plasmid-mediated AmpCs, ESBLs and the VIMtypecarbapenemases were sought by PCR amplification and subjected to direct sequencing.Susceptibility testing was performed with disk diffusion and ertapenem MICs were evaluatedwith the Etest method. Clonal relationship was investigated by either enterobacterial repetitiveintergenic consensus PCR (ERIC-PCR) or repetitive sequence based PCR (REP-PCR). FourAmpC inhibitors, cloxacillin (CLOX), phenyl-boronic acid (PBA), 3-acetyl-phenyl-boronic acid(APA) and 3-amino-phenyl-boronic (APBA) acid were evaluated, the latter in two finalconcentrations (300 and 600 μg/disk) with FOX, CTT, ceftazidime (CAZ) and cefotaxime (CTX)as substrates. Finally a modified CLSI ESBL test with the use of the aforementioned inhibitors andCTX and CAZ was evaluated.Altogether 59 isolates harbored plasmid-mediated AmpCs, with 35 also co-producing ESBLs.The MOX-2 β-lactamase was identified with the highest frequency followed by the CMY-2enzyme. CMY-4, CMY-13 and CMY-31 were also detected along with three novel to theregion enzymes, DHA-1 and two new AmpCs a CMY-4-like and a MIR-2-like. All P.mirabilisbelonged to one clonal type, K.oxytoca isolates presented two distinct clonal types whileK.pneumoniae and E.coli isolates presented 8 and 11 clonal types respectively.FOX resistance was found to be a discriminating parameter performing better than CTT as aninitial screening tool. In regards to the confirmatory phenotypic AmpC disk assay, FOX incombination with APBA produced the best results, successfully identifying 57/59 isolates. Theproposed modified CLSI ESBL test provided a significantly better overall performance whenperformed with CLOX (sensitivity 91,4% and specificity 75%), PBA (100%, 75%) and APBA(97,1%, 79,1%) in comparison to the standard CLSI ESBL test (85,7%, 58,3%). APA as an inhibitor failed to enhance the modified CLSI ESBL test exhibiting a suboptimal sensitivity of54,3%. Between January 2010 and June 2013, 132 non-repetitive carbapenem-resistantEnterobacteriaceae isolates, which gave positive the modified Hodge test (ΜΗΤ) and werephenotypically suspected of metallo-β-lactamase production (MBL), were recovered frompatients hospitalized in Ioannina University Hospital. Molecular testing verified the presencein 78 K. pneumoniae isolates, collected from 71 patients, of the blaNDM-1 gene. The blaCTX-M-15,blaOXA-1 and blaTEM-1 genes were also present in most isolates. The blaNDM-1 gene was locatedon an IncFII type plasmid, of c. 95kb, flanked upstream by a non-truncated ISAba125 elementand downstream by the bleMBL gene. Carbapenem resistance was transferable at a very low rateof ~ 1,3x10-7. Genotyping clustered all K. pneumoniae isolates into a single clonal type withone subtype and MLST assigned them to sequence type ST11. Two outbreaks were noted, thefirst between November-December 2011 involving four patients and the second initiated inMay 2012 and ongoing, involving the remaining patients. All but two cases were characterizedas hospital-acquired. No links to immigration or travel history to endemic areas wereestablished.From December 2011-March 2012, 13 ertapenem-resistant K. pneumoniae isolates, with apositive MHT, and negative phenotypic screening tests for MBL and KPC production, wererecovered from nine patients. All isolates harboured the blaOXA-48 gene along with blaCTX-M-15and blaOXA-1 genes. The blaOXA-48 gene was located on a self-transferable IncL/M-type plasmidof c. 62 kb, which harboured no other resistance genes. IS1999 was located upstream ofblaOXA-48 gene. Genetic disruptions of the OmpK35 and OmpK36 genes associated withpermeability defects were not detected. The isolates belonged to a unique PFGE clone andMLST assigned them to sequence type ST11. All cases were characterized as hospitalacquiredand none of them was linked to immigration or had a history of travel in endemicareas.Over a period of approximately 2,5 years initiated in 2010, three K.pneumoniae isolates were retrieved form urine samples of a single female patient, of which the first two with an intervalof 41 days, exhibiting resistance to cephamycins and extended spectrum cephalosporins, withpositive screening tests for AmpC β-lactamase production and a negative modified CLSIESBLtest. The initial two isolates exhibited carbapenem resistance, gave a positive ΜΗΤ andnegative screening tests for class A and B carbapenemase production.All isolates harbored the blaOXA-1 and blaDHA-1 genes and additionally the first two carried theblaOXA-162 gene. IS1999 was located upstream of blaOXA-162 gene. Genetic disruptions of theOmpK35 and OmpK36 genes associated with ertapenem resistance were not detected. Plasmidprofiling indicated the presence of three plasmids of ~140kb, ~62kb and 2kb in the first twowhile the latter lacked 62kb plasmid. Conjugation experiments failed to transfer β-lactamresistance. All K.pneumoniae belonged to a unique PFGE clone and MLST assigned them tosequence type ST11.

Degree

thesis:*
Grantor dc:publisher
National and Kapodistrian University of Athens
Year dc:date
2014

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Voulgari, Evangelia
  • Βούλγαρη, Ευαγγελία

Subjects

dc:subject × 16

Rights

dc:rights
Statement dc:rights
  • BY_NC_SA
Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/43655

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Voulgari, Evangelia; Βούλγαρη, Ευαγγελία. Επιδημιολογική μελέτη και διερεύνηση πλασμιδιακών AmpC β-λακταμασών και καρβαπενεμασών στα εντεροβακτηριοειδή στην ελληνική επικράτεια. National and Kapodistrian University of Athens, 2014. http://hdl.handle.net/10442/hedi/43655